Revi’s clinical success treating UUI: Dr. Sutherland’s perspective
Dr. Suzette Sutherland shares her excitement about the impressive clinical results seen with Revi for patients suffering from Urge Urinary Incontinence (UUI).
In this video, Dr. Suzette Sutherland shares her excitement about the impressive clinical results seen with Revi for treating urge urinary incontinence. The therapy’s success is attributed to two key factors: the surgical component with its placement under the fascia directly over the neurovascular bundle and daily stimulation. These factors combined have shown significant benefits to patients.
Dr. Sutherland also highlighted key findings from the OASIS pivotal study, which focused on urge incontinence. In the study, patients experienced an average of four and a half wetting episodes per day. Remarkably, in the study 82% of participants achieved more than the benchmark of 50% improvement. These results demonstrate Revi’s substantial effectiveness in reducing symptoms.
This testimonial represents the personal experience and opinion of the Physician. Dr. Sutherland is a BlueWind Medical consultant. Statements made during her presentation represents the experience of Dr. Sutherland. Patient response can and do vary.
MKL-0215 Rev. 01 Sep24